Support Full Access to FDA-Approved Alzheimer's Treatments

Last week, over 750 volunteer advocates, including those from right here in Illinois, were meeting with Members of Congress on Capitol Hill to urge lawmakers to make their voices heard in the fight against Alzheimer’s Disease and all other forms of dementia. I want to strengthen the work of my fellow advocates in D.C. by advocating from home in honor of my family members who have suffered with, been caregivers for, and died from this terrible disease.

Advocates across the country have been relentless in their efforts to shed light on the devastating toll of Alzheimer’s and other dementia. For the first time, we have two treatments for the early stages of Alzheimer’s disease that can drastically change the course of this fatal disease. While we should be celebrating this accomplishment, we instead are facing unprecedented barriers from CMS, as they are denying coverage of these two important treatments. We need CMS and our Members of Congress to hear our voices and act quickly to remove barriers to treatments. I’m calling on my Representative, Nikki Budzinski, to join our efforts and press CMS to remove barriers to treatment.

Every day, more than 2,000 people progress to a more advanced stage of Alzheimer’s, where they are no longer eligible for treatment. Treatment options for Alzheimer’s offers more time with loved ones, and I know that my family and I would love to have “more time” with family in the early stages of this disease process.

Please join me in asking Representative Budzinski to speak up on behalf of their constituents living with Alzheimer’s by urging CMS to remove the barriers on FDA-approved Alzheimer’s treatments. Every day matters to those facing Alzheimer’s disease and their families, so we must act now.